VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Biopharma Inc. (NYSE: VOR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Vor Biopharma Inc. (NYSE: VOR) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
Form 8-K Vor Biopharma Inc. For: Dec 09
Form SC 13G/A Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Chakraborty Tirtha
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: ANG ROBERT
Form 4 Vor Biopharma Inc. For: Nov 06 Filed by: Attar Eyal C.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.